Alex Goldberg

NYSE Decliners Watch List: U.S. Bancorp (NYSE:USB) and Merck & Co. Inc. (NYSE:MRK) Added to Equity Profile Report's NYSE Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/20/2013 -- -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding U.S. Bancorp (NYSE:USB) and Merck & Co. Inc. (NYSE:MRK).

U.S. Bancorp (NYSE:USB) a financial services holding company that provides a range of financial services in the United States closed down in its previous session (-0.20%) on 8,073,079 shares traded. U.S. Bancorp (NYSE:USB) is currently down (-1.67%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about U.S. Bancorp (NYSE:USB)

Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide closed down in its previous session (-0.22%) on 8,730,407 shares traded after Merck Collaborated with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma. Merck & Co. Inc. (NYSE:MRK) is currently down (-3.73%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com